A Phase II Clinical Trial to Evaluate the Potential of Concomitant Chemoradiotherapy With Gemcitabine in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease
Latest Information Update: 01 Jan 2024
At a glance
- Drugs Gemcitabine (Primary)
- Indications Adenocarcinoma; Carcinoma; Cervical cancer; Squamous cell cancer
- Focus Pharmacodynamics
- 26 Dec 2023 Planned End Date changed from 1 Apr 2022 to 1 Nov 2024.
- 26 Dec 2023 Planned primary completion date changed from 30 Nov 2021 to 1 Jul 2024.
- 08 Apr 2020 Planned End Date changed from 1 Jul 2019 to 1 Apr 2022.